MEDPLUSMedPlus Health ServicesMEDPLUS info
$8.11info0.09%24h
Global rank8055
Market cap$967.29M
Change 7d7.09%
YTD Performance-9.42%
SP500 benchmarkUnderperform
P/E1.94
P/S1.79
Revenue$539.96M
Earnings$5.97M
Dividend yield-
Main Sector
Healthcare

MedPlus Health Services (MEDPLUS) Stock Overview

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; and offers fast-moving consumer goods, such as toiletries, baby care products, soaps, detergents, and sanitizers. The company also provides wholesale cash and carry, and pathological laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. It operates stores in Karnataka, Tamil Nadu, Telangana, Andhra Pradesh, West Bengal, Maharashtra, Orissa, and Puducherry, as well as online stores. The company was incorporated in 2006 and is based in Hyderabad, India.

MEDPLUS Stock Information

Symbol
MEDPLUS
Address
H. No: 11-6-56Hyderabad, 500037India
Founded
-
Trading hours
-
Website
https://www.medplusindia.com
Country
🇮🇳 India
Phone Number
91 40 6724 6724

MedPlus Health Services (MEDPLUS) Price Chart

-
Value:-

MedPlus Health Services Overview: Key Details and Summary

Stock data
2023
Change
Price
$8.11
N/A
Market Cap
$967.29M
N/A
Shares Outstanding
119.31M
6.48%
Employees
19.63K
N/A
Shareholder Equity
14.91B
5.17%
Valuation
2023
Change
P/E Ratio
1.94
N/A
P/S Ratio
1.79
N/A
P/B Ratio
0.06
N/A
Growth
2023
Change
Return on Equity
0.0004
N/A
Earnings
2023
Change
Revenue
$539.96M
N/A
Earnings
$5.97M
N/A
EPS
4.17
N/A
Earnings Yield
0.5143
N/A
Gross Margin
0.2144
N/A
Operating Margin
0.0193
N/A
Net income margin
0.0111
N/A
Financial Strength
2023
Change
Total Assets
$333.45M
N/A
Total Debt
$107.30M
N/A
Cash on Hand
$34.28M
N/A
Debt to Equity
0.0104
5.54%
Cash to Debt
0.3195
-60.41%
Current Ratio
$3.11
6.44%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org